L-carnitine supplement for critically ill liver disease patients
Treatments studied
Part of Digestive system clinical trials.
This study tests whether adding L-carnitine (a naturally occurring compound) to standard care helps people with serious liver disease who are in the intensive care unit. L-carnitine may help the body use energy better and reduce complications from liver failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have confirmed liver disease and are admitted to an intensive care unit
- Your liver condition includes one or more of: acute-on-chronic liver failure, hepatic encephalopathy (brain effects from liver disease), spontaneous bacterial peritonitis, bleeding from stomach veins, fulminant hepatitis, hepatorenal syndrome, or ascites (fluid in the belly)
- You are not pregnant or breastfeeding
- You do not have a seizure disorder
- You are not currently taking the blood thinner warfarin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding L-carnitine (a natural substance) to your current treatment helps reduce rheumatoid arthritis symptoms. It could be an option if your arthritis is still active despite taking standard medications.
This study tests whether a supplement called L-carnitine can help diabetic foot ulcers heal faster. It is for people with type 2 diabetes who have mild to moderate foot ulcers and neuropathy (nerve damage in the feet).
This trial tests if a supplement called L-carnitine can help prevent kidney damage caused by the chemotherapy drug cisplatin. It may be an option for newly diagnosed cancer patients who need cisplatin treatment.
This study tests a medicine called carbocisteine to see if it can help treat nonalcoholic fatty liver disease (NAFLD). If you have a fatty liver and no other liver or kidney conditions, this trial may explore whether this drug is safe and effective for you.
This trial tests whether taking carnitine supplements by mouth can help people who have both heart failure and early-to-moderate kidney problems. It's an early-phase study to see if the supplement is safe and works for this group.
This trial tests whether a nutritional drink with L-carnitine can help people with lung cancer who are losing weight (cachexia) gain or maintain weight while on chemotherapy. L-carnitine may help the body use food better and reduce muscle loss.
Hear when a new Hepatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.